Inventor · disambiguated record
Muthusamy Shanmugam
Also filed as: SHANMUGAM MUTHUSAMY
5 granted patents·7 pending applications·5 citations·filing 2001–2025
67Inventor score
Technology areasA61K
Top patents by PatentIndex Score
12 records- 0186US11523993B1Dosage forms of tafamidis and its pharmaceutically acceptable salt thereofNURAY CHEMICALS PRIVATE LTD·Filed 2021·Granted Dec 13, 2022·5 cites·29 claims
- 0273US2025375376A1Stable oral liquid composition of terazosinNovitium Pharma LLC·Filed 2025·Application pending·0 cites
- 0371US11628143B1Tablet for oral suspensionNovitium Pharma LLC·Filed 2022·Granted Apr 18, 2023·0 cites·19 claims
- 0471US2024293325A1Tablet for oral suspensionNovitium Pharma LLC·Filed 2023·Application pending·0 cites
- 0569US2023398078A1Tablet for oral suspensionNovitium Pharma LLC·Filed 2023·Application pending·0 cites
- 0665US12427108B2Stable oral liquid composition of terazosinNovitium Pharma LLC·Filed 2021·Granted Sep 30, 2025·0 cites·17 claims
- 0762US11224572B1Stable oral liquid composition of terazosinNovitium Pharma LLC·Filed 2021·Granted Jan 18, 2022·0 cites·20 claims
- 0857US11878022B2Hydrochlorothiazide compositionsNovitium Pharma LLC·Filed 2022·Granted Jan 23, 2024·0 cites·20 claims
- 0952US2023149366A1Solid dosage forms of tafamidisNURAY CHEMICALS PRIVATE LTD·Filed 2022·Application pending·0 cites
- 1051US2023149365A1Dosage forms of tafamidis and its pharmaceutically acceptable salt thereofNURAY CHEMICALS PRIVATE LTD·Filed 2022·Application pending·0 cites
- 1144US2022184094A1Hydrochlorothiazide compositionsNovitium Pharma LLC·Filed 2021·Application pending·0 cites
- 1239US2003044462A1Sustained release tablets containing bupropion hydrochlorideKALI LAB INC·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Muthusamy Shanmugam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →